These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35153872)

  • 1. Gait Alterations in the Prediction of Metabolic Syndrome in Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles.
    Efthymiou D; Zekakos DX; Papatriantafyllou E; Ziagkas E; Petrelis AN; Vassilopoulou E
    Front Psychiatry; 2022; 13():756600. PubMed ID: 35153872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gait Analysis, Metabolic Parameters and Adherence to the Mediterranean Diet in Patients with Type 2 Diabetes Mellitus Compared with Healthy Controls: A Pilot Study.
    Efthymiou D; Katsiki N; Zekakos DX; Vassiliadis P; Petrelis A; Vassilopoulou E
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-Retest Reliability of PODOSmart
    Loukovitis A; Ziagkas E; Zekakos DX; Petrelis A; Grouios G
    Sensors (Basel); 2021 Nov; 21(22):. PubMed ID: 34833607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Tool for Gait Analysis: Validation Study of the Smart Insole PODOSmart
    Ziagkas E; Loukovitis A; Zekakos DX; Chau TD; Petrelis A; Grouios G
    Sensors (Basel); 2021 Sep; 21(17):. PubMed ID: 34502861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.
    Sneller MH; de Boer N; Everaars S; Schuurmans M; Guloksuz S; Cahn W; Luykx JJ
    Front Psychiatry; 2021; 12():625935. PubMed ID: 33868046
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome.
    Kim OY; Paik JK; Lee JY; Lee SH; Lee JH
    Clin Exp Hypertens; 2013; 35(5):382-8. PubMed ID: 23148723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics.
    Fang X; Wang Y; Chen Y; Ren J; Zhang C
    Neuropsychiatr Dis Treat; 2019; 15():2161-2170. PubMed ID: 31534339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia.
    Tay YH; Lee J
    Asian J Psychiatr; 2019 Jun; 43():1-6. PubMed ID: 31059867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between supination resistance and the kinetics and kinematics of the foot and ankle during gait.
    McBride S; Dixon P; Mokha M; Samuel Cheng M
    Gait Posture; 2019 Sep; 73():239-245. PubMed ID: 31376750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome.
    Kornetova EG; Kornetov AN; Mednova IA; Dubrovskaya VV; Boiko AS; Bokhan NA; Loonen AJM; Ivanova SA
    Front Psychiatry; 2019; 10():803. PubMed ID: 31736812
    [No Abstract]   [Full Text] [Related]  

  • 11. Macular Variability in Children and Adolescents with Metabolic Syndrome: A Cross-sectional Study Examining the Associations with Anthropometric Measurements, Metabolic Parameters and Inflammatory Markers.
    Öztürk H; Özen B; Çatlı G; Dündar BN
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):63-70. PubMed ID: 31434461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia.
    Lang X; Liu Q; Fang H; Zhou Y; Forster MT; Li Z; Zhang X
    Psychopharmacology (Berl); 2021 Dec; 238(12):3643-3652. PubMed ID: 34586464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and its association with the Dietary Inflammatory Index (DII)
    Kenđel Jovanović G; Pavičić Žeželj S; Klobučar Majanović S; Mrakovcic-Sutic I; Šutić I
    J Hum Nutr Diet; 2020 Feb; 33(1):128-137. PubMed ID: 31602707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population.
    Li Z; Wang S; Chen Y; Wu X; Gu Y; Lang X; Wu F; Zhang XY
    Int J Neuropsychopharmacol; 2021 Oct; 24(10):798-807. PubMed ID: 34153098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?
    Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB
    Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome.
    Torumtay G; Kırzıoğlu FY; Öztürk Tonguç M; Kale B; Calapoğlu M; Orhan H
    J Periodontal Res; 2016 Aug; 51(4):489-98. PubMed ID: 26547140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy.
    Fang X; Yu L; Wang D; Chen Y; Wang Y; Wu Z; Liu R; Ren J; Tang W; Zhang C
    Front Psychiatry; 2020; 11():602121. PubMed ID: 33324265
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome.
    Shin MJ; Shim E; Kang B; Park S; Lee SH; Shim CY; Park E; Chung N
    Yonsei Med J; 2009 Dec; 50(6):757-63. PubMed ID: 20046414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.